• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5106560)   Today's Articles (2723)
For: Marandino L, Campi R, Erdem S, Bertolo R, Marchioni M, Ingels A, Kara Ö, Carbonara U, Pecoraro A, Pavan N, Muselaers S, Roussel E, Amparore D. Finding novel prognostic factors in metastatic renal cell carcinoma: what does peripheral blood tell us? Minerva Urol Nephrol 2022;74:372-375. [PMID: 35607786 DOI: 10.23736/s2724-6051.22.04957-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Number Cited by Other Article(s)
1
Mollica V, Campi R, Amparore D, EAU Young Academic Urologists (YAU) Renal Cancer Working Group. YAU-RCC Spotlight: can we train immunity to cure RCC? Lessons from a neoantigen vaccine trial. Minerva Urol Nephrol 2025;77:425-427. [PMID: 40528781 DOI: 10.23736/s2724-6051.25.06511-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Collaborators] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/20/2025]
2
Ciccarese C, Mollica V, Marandino L, Palumbo C, Campi R, Amparore D. Adjuvant pembrolizumab prolongs overall survival in renal cell carcinoma at high-risk of recurrence after nephrectomy. Can we do better than this? Minerva Urol Nephrol 2024;76:540-544. [PMID: 39320246 DOI: 10.23736/s2724-6051.24.06114-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/26/2024]
3
Bertolo R, Amparore D, Muselaers S, Marchioni M, Wu Z, Campi R, Antonelli A. Thermal ablation for T1b renal cancer: an "I wish I could, but I cannot?". Minerva Urol Nephrol 2024;76:254-259. [PMID: 38742559 DOI: 10.23736/s2724-6051.24.05842-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2024]
4
Francolini G, Marandino L, Ciccarese C, Pecoraro A, Amparore D, Campi R. Metastatic de-novo renal cell carcinoma in the era of immune combinations: what can we learn from real-world data? Minerva Urol Nephrol 2024;76:120-123. [PMID: 38426426 DOI: 10.23736/s2724-6051.23.05640-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2024]
5
Roussel E, Amparore D, Bertolo R, Erdem S, Marchioni M, Pavan N, Campi R. Renal cell carcinoma with non-clear cell histologies: all the same peas in one pod? Minerva Urol Nephrol 2023;75:529-531. [PMID: 37530663 DOI: 10.23736/s2724-6051.23.05433-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/03/2023]
6
Marchioni M, Amparore D, Pecoraro A, Bertolo R, Campi R. Morbidity and mortality of metastasectomy for renal cell carcinoma: is centralization of care the way forward? Minerva Urol Nephrol 2023;75:413-416. [PMID: 37221833 DOI: 10.23736/s2724-6051.23.05365-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA